Fate Therapeutics, Inc.

FATE US31189P1021

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Valamehr Bahram CEO	1.06 USD	14,466 Sold	15,396 USD	04/08/2025	04/08/2025
Tahl Cindy O	1.06 USD	9,037 Sold	9,573 USD	04/08/2025	04/08/2025
Valamehr Bahram CEO	1.54 USD	8,705 Sold	13,406 USD	10/01/2025	10/01/2025
Bressi Jerome Charles O	1.55 USD	5,980 Sold	9,269 USD	10/01/2025	10/01/2025
Tahl Cindy O	1.55 USD	5,654 Sold	8,764 USD	10/01/2025	10/01/2025
Xu Yuan	4.23 USD	633 Sold	2,678 USD	06/08/2024	06/08/2024
Dulac Edward J Iii CFO	7.77 USD	2,447 Sold	19,013 USD	04/03/2024	04/03/2024
Dulac Edward J Iii CFO	5.00 USD	1,849 Sold	9,245 USD	29/01/2024	29/01/2024
Dulac Edward J Iii CFO	4.37 USD	7,028 Sold	30,712 USD	09/01/2024	09/01/2024
Valamehr Bahram SR OFF	4.38 USD	11,271 Sold	49,367 USD	09/01/2024	09/01/2024

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Fate Therapeutics, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Last	52W Low	52W High	All-Time Low	All-Time High	β

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Tahl Cindy	4	124,327.17	31,081.79	09/11/2023	04/08/2025
Dulac Edward J Iii	5	83,484.17	16,696.83	18/12/2023	04/03/2024
Valamehr Bahram	3	78,168.84	26,056.28	09/01/2024	04/08/2025
Wolchko J Scott	1	62,888.67	62,888.67	09/01/2024	09/01/2024
Bressi Jerome Charles	1	9,269.00	9,269.00	10/01/2025	10/01/2025
Xu Yuan	1	2,677.59	2,677.59	06/08/2024	06/08/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
INTELLIA THERAPEUTICS, INC.	US45826J1051	NTLA

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.